Inventor · disambiguated record
Matthew Duncton
Also filed as: DUNCTON MATTHEW · DUNCTON MATTHEW A J
33 granted patents·5 pending applications·85 citations·filing 2010–2023
96Inventor score
Files withRIGEL PHARMACEUTICALS INC31ARIXA PHARMACEUTICALS INC3DUNCTON MATTHEW1HOLLAND SACHA1SINGH RAJINDER1
Top patents by PatentIndex Score
38 records- 0193US9475781B2Fumarate analogs and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2015·Granted Oct 25, 2016·11 cites·28 claims
- 0292US10280161B2Aztreonam derivatives and uses thereofARIXA PHARMACEUTICALS INC·Filed 2018·Granted May 7, 2019·5 cites·27 claims
- 0388US9566278B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2015·Granted Feb 14, 2017·6 cites·21 claims
- 0486US8754251B2Cyclopropyl PIDA boronateRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Jun 17, 2014·4 cites·56 claims
- 0585US9321763B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Apr 26, 2016·6 cites·64 claims
- 0685US8377924B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2010·Granted Feb 19, 2013·9 cites·31 claims
- 0784US10941135B2Nrf2 activating compounds and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Mar 9, 2021·1 cites·23 claims
- 0884US9801866B2Fumarate analogs and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2016·Granted Oct 31, 2017·3 cites·27 claims
- 0984US9732070B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2016·Granted Aug 15, 2017·4 cites·27 claims
- 1083US9682976B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2016·Granted Jun 20, 2017·3 cites·55 claims
- 1183US9169249B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2014·Granted Oct 27, 2015·4 cites·17 claims
- 1281US9913843B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2015·Granted Mar 13, 2018·3 cites·5 claims
- 1381US9845307B2Nrf2 activating compounds and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2017·Granted Dec 19, 2017·2 cites·18 claims
- 1481US9701647B2Tetrazolones as a carboxylic acid bioisosteresRIGEL PHARMACEUTICALS INC·Filed 2016·Granted Jul 11, 2017·2 cites·5 claims
- 1581US9439888B2Tetrazolones as a carboxylic acid bioisosteresRIGEL PHARMACEUTICALS INC·Filed 2016·Granted Sep 13, 2016·2 cites·2 claims
- 1681US9181222B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2014·Granted Nov 10, 2015·4 cites·18 claims
- 1781US8722916B2Cyclopropyl MIDA boronateDUNCTON MATTHEW·Filed 2011·Granted May 13, 2014·3 cites·24 claims
- 1881US8710223B2Protein kinase C inhibitors and uses thereofHOLLAND SACHA·Filed 2011·Granted Apr 29, 2014·7 cites·2 claims
- 1980US9149475B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2012·Granted Oct 6, 2015·5 cites·21 claims
- 2076US9845311B2Nrf2 activating compounds and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2017·Granted Dec 19, 2017·1 cites·19 claims
- 2172US11279686B2Nrf2 activating compounds and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Mar 22, 2022·0 cites·15 claims
- 2272US11129819B2Fumarate analogs and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Sep 28, 2021·0 cites·22 claims
- 2368US10844040B2Nrf2 activating compounds and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Nov 24, 2020·0 cites·21 claims
- 2465US2022098175A1Direct ampk activatorsRIGEL PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2564US10556881B2Nrf2 activating compounds and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2017·Granted Feb 11, 2020·0 cites·17 claims
- 2663US10815228B2Aztreonam derivatives and uses thereofARIXA PHARMACEUTICALS INC·Filed 2019·Granted Oct 27, 2020·0 cites·29 claims
- 2763US10493066B2Fumarate analogs and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2017·Granted Dec 3, 2019·0 cites·3 claims
- 2863US9108990B2Cyclopropyl MIDA boronateRIGEL PHARMACEUTICALS INC·Filed 2014·Granted Aug 18, 2015·0 cites·19 claims
- 2962US2021009580A1Aztreonam derivatives and uses thereofARIXA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3061US10792282B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2018·Granted Oct 6, 2020·0 cites·17 claims
- 3160US2025129064A1Prodrugs of 2-bromo-lsd (2-bromolysergic acid diethylamide)TERRAN BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 3259US10647697B2Nrf2 activating compounds and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2017·Granted May 12, 2020·0 cites·19 claims
- 3359US10450280B2Tetrazolones as a carboxylic acid bioisosteresRIGEL PHARMACEUTICALS INC·Filed 2017·Granted Oct 22, 2019·0 cites·7 claims
- 3457US10005777B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2017·Granted Jun 26, 2018·0 cites·14 claims
- 3557US9062068B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Jun 23, 2015·0 cites·25 claims
- 3656US2017360786A1Protein Kinase C Inhibitors and Uses ThereofRIGEL PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3750US11174246B2Direct AMPK activatorsRIGEL PHARMACEUTICALS INC·Filed 2017·Granted Nov 16, 2021·0 cites·33 claims
- 3845US2011130415A1Protein kinase c inhibitors and uses thereofSINGH RAJINDER·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthew Duncton files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →